- 68
- 23 027
hVIVO plc
เข้าร่วมเมื่อ 27 ก.ค. 2020
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
The Group's fast-growing services business includes a unique portfolio of 11 human challenge models, with a number of new models under development, to test a broad range of infectious and respiratory disease products. The Company has world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing.
The Group's fast-growing services business includes a unique portfolio of 11 human challenge models, with a number of new models under development, to test a broad range of infectious and respiratory disease products. The Company has world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing.
hVIVO Year in Review 2024
2024 was an incredible year of achievements for the hVIVO Group. Over the past year we have moved to our new HQ in Canary Wharf, the world's largest commercial human challenge unit, and successfully expanded our service offering.
Check out some of the highlights of the year in our 2024 Year in Review!
hVIVO is committed to transforming global healthcare by revolutionising drug development process through scientific innovation and ingenuity.
Here's to even more milestones in 2025!
Check out some of the highlights of the year in our 2024 Year in Review!
hVIVO is committed to transforming global healthcare by revolutionising drug development process through scientific innovation and ingenuity.
Here's to even more milestones in 2025!
มุมมอง: 27
วีดีโอ
hVIVO's Senior Director of Patient Enrolment & Retention on Canary Wharf Facility
มุมมอง 582 หลายเดือนก่อน
hVIVO's Senior Director of Patient Enrolment & Retention on Canary Wharf Facility
hVIVO's Head of QA on the State-of-the-Art facility at Canary Wharf
มุมมอง 472 หลายเดือนก่อน
hVIVO's Head of QA on the State-of-the-Art facility at Canary Wharf
Describing the World's Largest Human Challenge Unit
มุมมอง 1274 หลายเดือนก่อน
Describing the world's largest human challenge trial facility in 3 words...or more! Check out what some of the members of management think about our new facility in Canary Wharf. Here are some key insights to our facility: ✅ Custom designed 👉 Total useable space increased by 31% 🔬 Capability to run multiple human challenge studies concurrently 👩🔬 Increased breadth of challenge models to includ...
Chief Scientific Officer on Human Challenge Trials & Canary Wharf State-of-the-Art facility
มุมมอง 3034 หลายเดือนก่อน
hVIVO's Chief Scientific Officer, Dr Andrew Catchpole discusses Human Challenge Trials and our new state-of-the-art facility in Canary Wharf
Director of Clinical Operations on hVIVO's State-of-the-Art Facility in Canary Wharf
มุมมอง 3074 หลายเดือนก่อน
Melanie Smyth discusses hVIVO's move to the state-of-the-art facility in Canary Wharf. hVIVO plc is a fast-growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growin...
hVIVO at Canary Wharf - Yamin 'Mo' Khan
มุมมอง 2964 หลายเดือนก่อน
CEO Yamin 'Mo' Khan on hVIVO's new headquartered state-of-the-art facility in Canary Wharf.
Opening of the World's Largest Human Challenge Trial Unit
มุมมอง 1514 หลายเดือนก่อน
Our grand opening of the world's largest human challenge trial unit in Canary Wharf was a great success! We were delighted to have so many industry colleagues, academics, clients and partners join us for this unveiling. 👨🔬 Guided tours of our state-of-the-art facility ✅ Presentations from management on the improved efficiencies 💪 Presentations & panel discussion with key opinion leaders 🥂 Netw...
Canary Wharf Facilities Walk Through Tour
มุมมอง 7095 หลายเดือนก่อน
Canary Wharf Facilities Walk Through Tour
Timeline Video hVIVO
มุมมอง 2895 หลายเดือนก่อน
We have an extensive history, that dates back to the UK Common Cold Unit in Salisbury which ran human challenge studies from 1946 until 1989. The facility was a former military hospital that was donated by Harvard University and began human challenge studies to try to find a cure for influenza. Our company's founders, Professor John Oxford, worked at the Common Cold Unit alongside Dr David Tyre...
hVIVO Joining the Life Science Hub at Canary Wharf
มุมมอง 3235 หลายเดือนก่อน
Our CEO speaks to the Canary Wharf group on our world leading title, human challenge trials & the move to Canary Wharf. Yamin 'Mo' Khan highlights out fit for purpose facility, our 50 bed quarantine unit and joining the life science community located at Canary Wharf.
Dr Andrew Catchpole on Omicron BA.5 Characterisation Study
มุมมอง 2696 หลายเดือนก่อน
Dr Andrew Catchpole, hVIVO's Chief Scientific Officer discusses the signed £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicron characterisation study. The manufacture of hVIVO's Omicron BA.5 challenge agent was successfully completed in 2023.
Laboratory Team Leader at hVIVO
มุมมอง 20311 หลายเดือนก่อน
We are delighted to introduce Sofia Zhao, our Laboratory 🔬 Team Leader at hVIVO! Sofia shares her day-to-day tasks and discusses what makes working at hVIVO so special. 🚀 Dive into the exciting world of our laboratory and discover why she enjoys being a part of our team! Ready to join us? Explore the possibilities on our careers page.
Ask the Experts: A Deep Dive Into Human Challenge Trials
มุมมอง 224ปีที่แล้ว
Ask the Experts: A Deep Dive Into Human Challenge Trials
Associate Medical Director Role at hVIVO
มุมมอง 108ปีที่แล้ว
Associate Medical Director Role at hVIVO
hVIVO Canary Wharf Facilities - Adam French
มุมมอง 423ปีที่แล้ว
hVIVO Canary Wharf Facilities - Adam French
hVIVO Careers - Fueling Scientific Research
มุมมอง 637ปีที่แล้ว
hVIVO Careers - Fueling Scientific Research
Developing an Influenza B Human Challenge Model
มุมมอง 220ปีที่แล้ว
Developing an Influenza B Human Challenge Model
VP of Clinical Operations on hVIVO's new Facility
มุมมอง 297ปีที่แล้ว
VP of Clinical Operations on hVIVO's new Facility
hVIVO to Develop hMPV Human Challenge Model
มุมมอง 197ปีที่แล้ว
hVIVO to Develop hMPV Human Challenge Model
Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines
มุมมอง 178ปีที่แล้ว
Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines
hVIVO at World Vaccine Congress Washington 2023
มุมมอง 346ปีที่แล้ว
hVIVO at World Vaccine Congress Washington 2023
Director of Business Development Egle Payvde Discusses BioEurope Spring Event
มุมมอง 273ปีที่แล้ว
Director of Business Development Egle Payvde Discusses BioEurope Spring Event
Venn Life Sciences new offices at Leiden BioScience Park
มุมมอง 252ปีที่แล้ว
Venn Life Sciences new offices at Leiden BioScience Park
Venn Life Sciences €3.2m Contract Win with Global Pharma Company
มุมมอง 165ปีที่แล้ว
Venn Life Sciences €3.2m Contract Win with Global Pharma Company
Excellent update, thank you for sharing
Thank you for sharing, excellent day's events
Quarantine for what?
That would depend on the customers requirements.ghe whole consept is to infect healthy volunteers with doses of whatever the customer needs info on.
This video is misleading. Myself and everyone I know who's done a trial with flu camp were put in a boxy hospital style room with no window for natural light. The only window was facing the main medical staff 'hub' where there's constant noise and lights on all the time. Also, you're not allowed to close the blind so that they can monitor you at all times.
A video discussing bricks n mortar facikities which is 100% talking head. Couldn'y you even slip in 1 architects drawing? Was it unreasonable to expect pictures of facilities in a video entitled Facilities? It sounds great. I'm sure you have plans. Top secret?
Which building is it?
Therapeutics? Or are they not profitable enough.
Didn't Hvivo do the Phase 1 Challange Study for a Codagenix's (CoviLiv) Covid Vaccine candidate. It's now in Phase 3 in collaboration with The Serum Institute of India.
Easy to speed up rolling out vaccines, don't spend years testing them for effectiveness or safety.
You shouldn't be smiling so much.
When the time comes..... We see you.
mRNA vaccines are the US Military's bioweapon & everyone involved will be EXECUTED for WAR Crimes.
Agreed... All of them. Their synthetic biology can cause so much danger .... These people are clinically obsessed and are a danger to themselves and to others.
Don't you mean mid 2024?
this is an old video. There was due to be a challenge study this year ifyou read the company RNSs you will see
𝖕𝖗𝖔𝖒𝖔𝖘𝖒
Is there a gym to use or is physical activity involved in the tests? I think I'd need to exercise to prevent losing my mind.
Exactly what I was thinking..
They say on their website you cant exercise a lot i think
Can I work out during the trials? During our trials we kindly ask that our volunteers refrain from strenuous exercise. Pacing and light yoga are fine; however more intense activity can interfere with the tests our nursing staff are required to perform to gather data and check patient health. We provide lots of alternative entertainments available for our volunteers while they are with us including TVs, games, books and brainteasers.
Very professional. Let's hope they keep Cathal Friel in the basement,never to be heard again
Well done Cathal 🥳👍
I signed up, after 14 days wouldn’t you be a bit loopy